Novel poly(ethylene glycol) modified compounds and uses thereof
Details for Australian Patent Application No. 2004238869 (hide)
International Classifications
Event Publications
5 January 2006 PCT application entered the National Phase
PCT publication WO2004/101600 Priority application(s): WO2004/101600
25 June 2009 Amendment Made
The nature of the amendment is: Amend the co-inventor name from Holmes, Chris to Holmes, Christopher P.; from Yin, Kevin to Yin, Qun and delete the co-inventors name Balu, Palani; Schatz, Peter and Lalonde, Guy
25 June 2009 Application Accepted
Published as AU-B-2004238869
22 October 2009 Standard Patent Sealed
10 December 2009 Licence Registered
Affymax, Inc. ( Takeda Pharmaceutical Company Limited ) Mortgages Registered - Section 187, Reg. 19 (The name in the parentheses is that of the mortgagee)
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004238870-Novel peptides that bind to the erythropoietin receptor
2004238868-Peptides that bind to the erythropoietin receptor
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser